EADV 2026: Lebrikizumab improved hand and foot clearance, itch, and pain at 16 weeks versus placebo in a phase 3b atopic dermatitis trial.
News|Poll|March 21, 2014
Itchy Rash on a Young Man’s Chest
An otherwise healthy 24-year-old man is concerned about this mildly pruritic, scaly rash on his chest, which erupted during the late spring. What do you suspect is the diagnosis?
Advertisement
An otherwise healthy 24-year-old man is concerned about this mildly pruritic, scaly rash on his chest, which erupted during the late spring. He has no other skin lesions.
What do you suspect is the diagnosis?
Advertisement
Related to this article
The FDA has approved baricitinib for adolescents aged 12 and older with severe alopecia areata, marking the first systemic oral therapy cleared for this population.
Takeda’s oral TYK2 inhibitor showed rapid skin clearance in phase 3 psoriasis trials as FDA fast-tracks review; decision expected early 2027.
Advertisement
Advertisement
Trending on Patient Care Online
1
Atrial Fibrillation Stroke Prevention: Expert Guidance for Primary Care Physicians
2
5 FDA Decisions for Primary Care to Know from September 2026
3
Fezolinetant Linked to 2.6 Fewer Nighttime Awakenings in Women With Menopausal VMS
4
Lebrikizumab Improves Hand and Foot Atopic Dermatitis in Phase 3b Trial
5